KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Payables (2016 - 2025)

Historic Payables for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $209.7 million.

  • Astrana Health's Payables rose 11974.77% to $209.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $209.7 million, marking a year-over-year increase of 11974.77%. This contributed to the annual value of $106.8 million for FY2024, which is 7624.24% up from last year.
  • According to the latest figures from Q3 2025, Astrana Health's Payables is $209.7 million, which was up 11974.77% from $119.7 million recorded in Q2 2025.
  • Astrana Health's Payables' 5-year high stood at $209.7 million during Q3 2025, with a 5-year trough of $40.7 million in Q1 2021.
  • For the 5-year period, Astrana Health's Payables averaged around $79.0 million, with its median value being $58.1 million (2021).
  • Per our database at Business Quant, Astrana Health's Payables surged by 19334.2% in 2024 and then crashed by 2781.17% in 2025.
  • Over the past 5 years, Astrana Health's Payables (Quarter) stood at $44.5 million in 2021, then grew by 12.85% to $50.2 million in 2022, then rose by 20.63% to $60.6 million in 2023, then surged by 76.24% to $106.8 million in 2024, then surged by 96.43% to $209.7 million in 2025.
  • Its last three reported values are $209.7 million in Q3 2025, $119.7 million for Q2 2025, and $106.2 million during Q1 2025.